Pops up on my Fidelity news..
Quote:ValuEngine resumes coverage for AMARANTUS BIOSCI INC with SELL recommendation.
BY Investars Analyst Actions - public
— 7:13 AM ET 01/06/2015
On January 5, 2015 ValuEngine resumed coverage for AMARANTUS BIOSCI INC with a SELL recommendation.